Staff

All professionals at Miodrag Velickovic, MD maintain the highest levels of accreditation and pursue ongoing education to stay abreast of the latest trends in the medical field. Read on to learn more about our staff's experience and training.

Miodrag Velickovic, MD

Miodrag Velickovic, MD

Certification

Neurology, American Board of Psychiatry and Neurology

Research Topics

Apoptosis/Cell Death, Autophagy, Blepharospasm, Botulinum toxin (Botox) treatments  Brain, Brain Imaging, Bruxism, Cerebellum, Cerebral Cortex, Cervical Dystonia, Cortical Basilar Degeneration (CBD), Frontotemporal Dementia (FTD), Dementia, Drug Design and Discovery, Dystonia, Gene Discovery, Gene Expressions, Gene Regulation, Gene Therapy, Genetics of Movement disorders, Headache,  MRI (erase MRI) Laryngeal dystonia, Myoclonus, Neuro-degeneration/protection, Neurophysiology, Neuroscience, Oromandibular Dystonia, Parkinson's Disease, Progressive Supranuclear Palsy (PSP), Speech, Spasmodic Dysphonia, Spasmodic Torticollis, Spasticity, Stroke, Tremor, Vocal Tract, Wilson’s disease

Education

Fellowship: Movement Disorders Mount Sinai Hospital

Residency: Neurology NYU-Langone Medical Center, Internship Internal Medicine Nassau County Medical Center Residency.

MD: University of Nis

Languages

English, Serbo-Croatian

Professional Membership

  • American Academy of Neurology
  • European Academy of Neurology
  • Movement Disorders Society
  • Parkinson Study Group
  • Dystonia Medical Research Foundation
  • International Headache Society

Publications:

2016 Neural correlates of abnormal sensory discrimination in laryngeal dystonia.

2014 What's special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study.

2008 Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

2008 Cervical dystonia: etiology and pathophysiology.

2007 R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.

2006 Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. 7

2004 Corticospinal excitability accompanying ballistic wrist movements in primary dystonia.

2004 Parkinson's disease without expected neuropathologic abnormality.

2003 Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

2002 Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations.

2002 Autonomic cardiovascular reflexes in Wilson's disease.

2002 Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

2002 Clinical findings of a myoclonus-dystonia family with two distinct mutations.

2002 Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families.

2002 Movement disorders. Keys to identifying and treating tremor.

2001 Cervical dystonia pathophysiology and treatment options.

2001 Myoclonus

1940 Commerce St #107 Yorktown Heights, NY 10598